COVID-19: What Should the General Practitioner Know?

References

• Cui J, Li F, Shi Z. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181–192. doi:10.1038/s41579-018-0118-930531947
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi:10.1038/s41586-020-2012-732015507
   PubMed Web of Science ®Google Scholar
• Ji W, Wang W, Zhao X, Zai J, Li X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol. 2020;92:433–440. doi:10.1002/jmv.2568231967321
   PubMed Web of Science ®Google Scholar
• Perera KD, Galasiti Kankanamalage AC, Rathnayake AD, et al. Protease inhibitors broadly effective against feline, ferret and mink coronaviruses. Antiviral Res. 2018;160:79–86. doi:10.1016/j.antiviral.2018.10.01530342822
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. China medical treatment expert group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708–1720. doi:10.1056/NEJMoa200203232109013
   PubMed Web of Science ®Google Scholar
• Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355–368. doi:10.1097/INF.000000000000266032310621
   PubMed Web of Science ®Google Scholar
• Zhao XY, Xu XX, Yin HS, et al. Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. BMC Infect Dis. 2020;20:311. doi:10.1186/s12879-020-05010-w32345226
   PubMed Web of Science ®Google Scholar
• Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS.SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24(7):4016–4026. doi:10.26355/eurrev_202004_2087132329877
   PubMed Web of Science ®Google Scholar
• Li X, Zeng W, Li X, et al. CT imaging changes of corona virus disease 2019(COVID-19): a multicenter study in Southwest China. J Transl Med. 2020;18(1):154. doi:10.1186/s12967-020-02324-w32252784
   PubMed Web of Science ®Google Scholar
• To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;S1473-3099(20). doi:10.1016/S1473-3099(20)30196-1
   Web of Science ®Google Scholar
• Yu F, Du L, Ojcius DM, Pan C, Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020;22:74–79. doi:10.1016/j.micinf.2020.01.00332017984
   PubMed Web of Science ®Google Scholar
• Hindson J. COVID-19: faecal-oral transmission? Nat Rev Gastroenterol Hepatol. 2020;17:259. doi:10.1038/s41575-020-0295-732214231
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
   PubMed Web of Science ®Google Scholar
• Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7:66‐ 75. doi:10.3945/an.115.010207
   Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. doi:10.1001/jama.2020.1585
   Web of Science ®Google Scholar
• Flisiak R, Horban A, Jaroszewicz J, et al. Rekomendacje postępowania z infekcjami koronawirusem Polskiego Towarzystwa Epidemiologów i Zakaźników. Termedia. 2020 https://www.termedia.pl/zalecenia/Rekomendacje-postepowania-z-infekcjami-koronawirusem-Polskiego-Towarzystwa-Epidemiologow-i-Zakaznikow,37396.html.
   Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;S2213-2600(20). doi:10.1016/S2213-2600(20)30079-5
   Web of Science ®Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239. doi:10.1001/jama.2020.264832091533
   PubMed Web of Science ®Google Scholar
• ECDC. European-Centre-for-Disease-Prevention-and-Control. Daily risk assessment on COVID-19, 2 March 2020 Available from: https://www.ecdc.europa.eu/en/current-risk-assessment-novel-coronavirus-situation. Accessed 1210, 2020.
   Google Scholar
• Zheng. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16:1678–1685. doi:10.7150/ijbs.4505332226285
   PubMed Web of Science ®Google Scholar
• Wu X, Dong D, Ma D. Thin-section computed tomography manifestations during convalescence and long-term follow-up of patients with Severe Acute Respiratory Syndrome (SARS). Med Sci Monit. 2016;22:2793–2799. doi:10.12659/MSM.89698527501327
   PubMed Web of Science ®Google Scholar
• Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol. 2014;203:782–787. doi:10.2214/AJR.14.1302124918624
   PubMed Web of Science ®Google Scholar
• Peeri NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020;pii:dyaa033. doi:10.1093/ije/dyaa033
   Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi:10.1016/S0140-6736(20)30251-832007145
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. China novel coronavirus investigating and research team. a novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. doi:10.1056/NEJMoa200101731978945
   PubMed Web of Science ®Google Scholar
• Ye ZW, Yuan S, Yuen KS, Fung SY, Chan CP, Jin DY. Zoonotic origins of human coronaviruses. Int J Biol Sci. 2020;16:1686–1697. doi:10.7150/ijbs.4547232226286
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-2019) situation reports. Situation report e 33. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed 1210, 2020.
   Google Scholar
• Burki T. Outbreak of coronavirus disease 2019. Lancet Infect Dis. 2020;S1473-3099.
   Google Scholar
• Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015;28:465–522.25810418
   PubMed Web of Science ®Google Scholar
• Cheng VCC, Lau SKP, Woo PCY, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20:660–694.17934078
   PubMed Web of Science ®Google Scholar
• Gu J, Han B, Wang J. COVID-19: gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020;158(6):1518–1519. doi:10.1053/j.gastro.2020.02.05432142785
   PubMed Web of Science ®Google Scholar
• Lee IK, Wang CC, Lin MC, Kung CT, Lan KC, Lee CT. Effective strategies to prevent coronavirus disease-2019 (COVID-19) outbreak in hospital. J Hosp Infect. 2020. doi:10.1016/j.jhin.2020.02.022
   Web of Science ®Google Scholar
• Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177–1179. doi:10.1056/NEJMc200173732074444
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–1207. doi:10.1056/NEJMoa200131631995857
   PubMed Web of Science ®Google Scholar
• Zhang J, Litvinova M, Wang W, et al. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect Dis. 2020. doi:10.1016/S1473-3099(20)30230-9
   Web of Science ®Google Scholar
• Linton NM, Kobayashi T, Yang Y, et al. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med. 2020;9(2):E538. doi:10.3390/jcm902053832079150
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Yu XJ, Fu T, et al. Novel coronavirus infection in newborn babies aged 28days. Eur Respir J. 2020;55(6):2000697. doi:10.1183/13993003.00697-202032269087
   PubMed Web of Science ®Google Scholar
• Liu W, Wang J, Li W, Zhou Z, Liu S, Rong Z. Clinical characteristics of 19 neonates born to mothers with COVID-19. Front Med. 2020. doi:10.1007/s11684-020-0772-y
   Web of Science ®Google Scholar
• Epidemiology Working Group for NCIP Epidemic Response CCfDCaP. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese J Epidemiol. 2020;41:145–151.
   Google Scholar
• World Health Organization. World Report on Aging and Health. Luxembourg: WHO; 2015.
   Google Scholar
• Wei M, Yuan J, Liu Y, Fu T, Yu X, ZJ Z. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020;323(13):1313. doi:10.1001/jama.2020.213132058570
   PubMed Web of Science ®Google Scholar
• Cai J, Xu J, Lin D, et al. A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis. 2020;pii:ciaa198. doi:10.1093/cid/ciaa198
   Web of Science ®Google Scholar
• Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults. Pediatr Pulmonol. 2020;55(5):1169–1174. doi:10.1002/ppul.2471832134205
   PubMed Web of Science ®Google Scholar
• Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta‐analysis of individual participant data. BMJ. 2017;356:i6583. doi:10.1136/bmj.i658328202713
   PubMed Web of Science ®Google Scholar
• To KK, Tsang OT, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva [published on February 12, 2020]. Clin Infect Dis. 2020;pii:ciaa149. doi:10.1093/cid/ciaa149
   Web of Science ®Google Scholar
• Mao R, Liang J, Wu KC, Chen MH. Responding to COVID-19: perspectives from the Chinese Society of Gastroenterology. Gastroenterology. 2020.
   Web of Science ®Google Scholar
• Luo S, Zhang X, Xu H. Don’t overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19. Clin Gastroenterol Hepatol. 2020;18(7):1636–1637. doi:10.1016/j.cgh.2020.03.04332205220
   PubMed Web of Science ®Google Scholar
• Chai X, Longfei H, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. biorxiv. 2020:931766 DOI:10.1101/2020.02.03.931766
   Google Scholar
• Leung WK, To KF, Chan PK, et al. Enteric involvement of severe acute respiratory syndrome associated coronavirus infection. Gastroenterology. 2003;25(4):1011–1017. doi:10.1016/j.gastro.2003.08.001
   Web of Science ®Google Scholar
• European Rhinologic Society. Information for rhinologists on COVID-19. Available from: https://www.europeanrhinologicsociety.org/?page_id=2143. Accessed 1210, 2020.
   Google Scholar
• Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–2261. doi:10.1007/s00405-020-05965-132253535
   PubMed Web of Science ®Google Scholar
• Russell FM, Reyburn R, Chan J, et al. Impact of the change in WHO’s severe pneumonia case definition on hospitalized pneumonia epidemiology: case studies from six countries. Bull World Health Organ. 2019;97:386–393.31210676
   PubMed Web of Science ®Google Scholar
• Lin X, Gong Z, Xiao Z, Xiong J, Fan B, Liu J. Novel coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases. Korean J Radiol. 2020;21:365–368. doi:10.3348/kjr.2020.007832056397
   PubMed Web of Science ®Google Scholar
• Fang Y, Zhang H, Xie J, et al. Sensitivity of Chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;19:200432.
   Web of Science ®Google Scholar
• Wu J, Liu J, Li S, et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients. Travel Med Infect Dis. 2020;37:101673. doi:10.1016/j.tmaid.2020.10167332311437
   PubMed Web of Science ®Google Scholar
• Tang B, Wang X, Li Q, et al. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med. 2020;9:1–13. doi:10.3390/jcm9020462
   Web of Science ®Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:1–8. doi:10.2807/1560-7917.ES.2020.25.3.2000045
   Google Scholar
• CDC. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19) Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html. Accessed 1210, 2020.
   Google Scholar
• NEJM. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Available from: https://www.nejm.org/doi/full/10.1056/NEJMc2001737. Accessed 1210, 2020.
   Google Scholar
• Lin C, Xiang J, Yan M, Li H, Huang S, Shen C. Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19). Clin Chem Lab Med. 2020;58(7):1089–1094. doi:10.1515/cclm-2020-018732301745
   PubMed Web of Science ®Google Scholar
• Mash MB. Primary care management of the coronavirus (COVID-19). S Afr Fam Pract. 2004;2020(62):e1–e4.
   Google Scholar
• Jin YH, Cai L, Cheng ZS, et al. Evidence-based medicine chapter of china international exchange and promotive association for medical and health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4. doi:10.1186/s40779-020-0233-632029004
   PubMed Web of Science ®Google Scholar
• Yan G, Lee CK, Lam LTM, et al. Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis. 2020;S1473-3099(20). doi:10.1016/S1473-3099(20)30158-4
   Web of Science ®Google Scholar
• Vincent JL, Moreno R, Takala J, et al. (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society. Intensive Care Med. 1996;22:707–710. doi:10.1007/BF17097518844239
   PubMed Web of Science ®Google Scholar
• Kwon YS, Baek MS. Development and validation of a quick sepsis-related organ failure assessment-based machine-learning model for mortality prediction in patients with suspected infection in the emergency department. J Clin Med. 2020;9(3):E875. doi:10.3390/jcm903087532210033
   PubMed Web of Science ®Google Scholar
• Hu H, Yao N, Qiu Y. Comparing rapid scoring systems in mortality prediction of critical ill patients with novel coronavirus disease. Acad Emerg Med. 2020;27(6):461–468. doi:10.1111/acem.1399232311790
   PubMed Web of Science ®Google Scholar
• Liu JW, Lu SN, Chen SS, et al. Epidemiologic study and containment of a nosocomial outbreak of severe acute respiratory syndrome in a medical center in Kaohsiung, Taiwan. Infect Control Hosp Epidemiol. 2006;27:466–472. doi:10.1086/50450116671027
   PubMed Web of Science ®Google Scholar
• Yousefifard M, Zali A, Mohamed AK, et al. Antiviral therapy in management of COVID-19: a systematic review on current evidence. Arch Acad Emerg Med. 2020;8:e45.32309809
   PubMedGoogle Scholar
• Damle B, Vourvahis M, Wang E, Leaney J, Corrigan B. Clinical pharmacology perspectives on the antiviral activity of azithromycin and use in COVID-19. Clin Pharmacol Ther. 2020;108(2):201–211. doi:10.1002/cpt.185732302411
   PubMed Web of Science ®Google Scholar
• Wu R, Wang L, Kuo HD, et al. An update on current therapeutic drugs treating COVID-19 [published online ahead of print, 2020 May 11]. Curr Pharmacol Rep. 2020:1‐15. doi:10.1007/s40495-020-00216-7.
   Google Scholar
• Wang, Wang Y, Zhang D, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 2020;395(10236):1569–1578.
   PubMed Web of Science ®Google Scholar
• Grein et al. 2020 Compassionate Use of Remdesivir for Patients with Severe Covid-19. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2007016. Accessed 1210, 2020.
   Google Scholar
• Liu J, Cao R, Xu M, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6(16). doi:10.1038/s41421-020-0156-0
   Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269–271. doi:10.1038/s41422-020-0282-032020029
   PubMed Web of Science ®Google Scholar
• Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi:10.1016/j.ijantimicag.2020.10594932205204
   PubMed Web of Science ®Google Scholar
• Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;pii:ciaa237. doi:10.1093/cid/ciaa237
   Web of Science ®Google Scholar
• Cao, Cao B, Wang Y, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. NEJM. 2020;382(19):1787–1799.32187464
   PubMed Web of Science ®Google Scholar
• Ye, et al. Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019. Eur Rev Med Pharmacol Sci. 2020;24(6):3390–3396. doi:10.26355/eurrev_202003_2070632271456
   PubMed Web of Science ®Google Scholar
• Xiaoling et al. 2020 Effective Treatment of Severe COVID-19 Patients with Tocilizumab. pdf download
   Google Scholar
• Gritti G, et al. Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support. medRxiv. 2020.
   Google Scholar
• Caly L, Druce JD, et al. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. 2020;178:104787. doi:10.1016/j.antiviral.2020.10478732251768
   PubMed Web of Science ®Google Scholar
• Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 2020;323(16):1582. doi:10.1001/jama.2020.478332219428
   PubMed Web of Science ®Google Scholar
• Duan, et al. The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study. MedRxiv. doi:10.1101/2020.03.16.20036145
   Google Scholar
• Villar, Villar J, Ferrando C, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8(3):267–276. doi:10.1016/S2213-2600(19)30417-532043986
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020. doi:10.1111/jth.14817
   Web of Science ®Google Scholar
• Zhong M, Sun A, Xiao T, et al. A randomized, single-blind, group sequential, active-controlled study to evaluate the clinical efficacy and safety of α-Lipoic acid for critically ill patients with coronavirus disease 2019 (COVID-19) (preprint). Pharmacol Ther. 2020. doi:10.1101/2020.04.15.20066266
   Google Scholar
• McCarty MF, DiNicolantonio JJ. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Prog Cardiovasc Dis. 2020;63(3):383–385. doi:10.1016/j.pcad.2020.02.00732061635
   PubMed Web of Science ®Google Scholar
• Schultz MJ, Dunser MW, Dondorp AM, et al. Global Intensive Care Working Group of the European Society of Intensive Care Medicine. Intensive Care Med. 2017;43:612–624. doi:10.1007/s00134-017-4750-z28349179
   PubMed Web of Science ®Google Scholar
• Shah S, Das S, Jain A, Misra DP, Negi VS. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Int J Rheum Dis. 2020;23(5):613–619. doi:10.1111/1756-185X.1384232281213
   PubMed Web of Science ®Google Scholar
• Horby P, WS L, Emberson J, et al. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report RECOVERY Collaborative Group medRxiv 2020. doi: 10.1101/2020.06.22.20137273
   Google Scholar
• Tobin MJ, Laghi F, Jubran A. Caution about early intubation and mechanical ventilation in COVID-19. Ann Intensive Care. 2020;10(78). doi:10.1186/s13613-020-00692-6
   Web of Science ®Google Scholar
• Dondorp AM, Hayat M, Aryal D, Beane A, Schultz MJ. Respiratory support in COVID-19 patients, with a focus on resource-limited settings. Am J Trop Med Hyg. 2020;102(6):1191–1197. doi:10.4269/ajtmh.20-028332319424
   PubMed Web of Science ®Google Scholar
• Masotti P, Green ME, Birtwhistle R, et al. pH1N1 — a comparative analysis of public health responses in Ontario to the influenza outbreak, public health and primary care: lessons learned and policy suggestions. BMC Public Health. 2013;13:687. doi:10.1186/1471-2458-13-68723890226
   PubMed Web of Science ®Google Scholar
• Modenese A, Gobba F. Increased risk of COVID-19-related deaths among general practitioners in Italy. Healthcare (Basel). 2020;2:155. doi:10.3390/healthcare8020155
   Google Scholar
• Ing EB,  Xu QA, Salimi A, Torun N. Physician deaths from corona virus (COVID-19) disease. Occup Med (Lond) Actions 2020;
   Google Scholar
• Li DKT, Zhu S. Contributions and challenges of general practitioners in China fighting against the novel coronavirus crisis. Fam Med Com Health. 2020;8(2):e000361. doi:10.1136/fmch-2020-000361
   Web of Science ®Google Scholar